Small fiber neuropathy.
autonomic dysfunction
outcome
pain
small fiber neuropathy
treatment
Journal
Acta neurologica Scandinavica
ISSN: 1600-0404
Titre abrégé: Acta Neurol Scand
Pays: Denmark
ID NLM: 0370336
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
revised:
19
01
2022
received:
10
01
2022
accepted:
24
01
2022
pubmed:
8
2
2022
medline:
6
4
2022
entrez:
7
2
2022
Statut:
ppublish
Résumé
Small fiber neuropathy (SFN) is a peripheral nervous system disease due to affection of A-delta or C-fibers in a proximal, distal, or diffuse distribution. Selective SFN (without large fiber affection) manifests with pain, sensory disturbances, or autonomic dysfunction. Though uniform diagnostic criteria are unavailable, most of them request typical clinical features and reduced intra-epidermal nerve fiber density on proximal or distal skin biopsy. Little consensus has been reached about the treatment of SFN, why this narrative review aims at summarizing and discussing treatment options for SFN. Treatment of SFN can be classified as symptomatic, pathophysiologic, or causal. Prerequisites for treating SFN are an established diagnosis, knowledge about the symptoms and signs, and the etiology. Pain usually responds to oral/intravenous pain killers, antidepressants, anti-seizure drugs, or topical, transdermal specifications. Some of the autonomic disturbances respond favorably to symptomatic treatment. SFN related to Fabry disease or hATTR are accessible to pathogenesis-related therapy. Immune-mediated SFN responds to immunosuppression or immune-modulation. Several of the secondary SFNs respond to causal treatment of the underlying disorder. In conclusion, treatment of SFN relies on a multimodal concept and includes causative, pathophysiologic, and symptomatic measures. It strongly depends on the clinical presentation, diagnosis, and etiology, why it is crucial before initiation of treatment to fix the diagnosis and etiology. Due to the heterogeneous clinical presentation and multi-causality, treatment of SFN should be individualized with the goal of controlling the underlying cause, alleviating pain, and optimizing functionality.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
493-503Informations de copyright
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Milner R, Doherty C. Chapter 1 - Pathophysiology of pain in the peripheral nervous system. Nerves and injuries Vol 2: Pain, Treatment, Injury, Disease and Future Directions. Academic Press; 2015:3-22.
Fileccia E, Incensi A, Ventruto F, et al. Small fiber neuropathy in patients with chronic pain and a previous diagnosis of multiple chemical sensitivity syndrome. J Neuropathol Exp Neurol. 2021;80(9):868-874. doi:10.1093/jnen/nlab082
Opsommer E, Masquelier E, Plaghki L. Determination of nerve conduction velocity of C-fibres in humans from thermal thresholds to contact heat (thermode) and from evoked brain potentials to radiant heat (CO2 laser). Neurophysiol Clin. 1999;29(5):411-422. doi:10.1016/S0987-7053(00)87265-2
Sène D. Small fiber neuropathy: Diagnosis, causes, and treatment. Joint Bone Spine. 2018;85(5):553-559. doi:10.1016/j.jbspin.2017.11.002
Gibbons CH. Small fiber neuropathies. CONTINUUM: Lifelong Learning Neurol. 2014;20:1398-1412.
Li C, Wang W, Ni W, et al. Better islet function and cardiovascular autonomic function in Chinese type 2 diabetic patients with pure small fiber neuropathy than with mixed neuropathy. Diabetes Ther. 2021;12(9):2423-2436. doi:10.1007/s13300-021-01111-0
Pál E, Fülöp K, Tóth P, et al. Small fiber neuropathy: clinicopathological correlations. Behav Neurol. 2020;2020:8796519. doi:10.1155/2020/8796519
Martínez-Lavín M. Dorsal root ganglia: fibromyalgia pain factory? Clin Rheumatol. 2021;40(2):783-787. doi:10.1007/s10067-020-05528-z
Contijoch Roqueta C, Izquierdo MF, Arrabal SL. Neuropatía de fibras pequeñas: una revisión Small fibre neuropathy: a review. Semergen. 2020;46(4):277-282. doi:10.1016/j.semerg.2019.11.003
Gomatos EL, Rehman A. Sensory neuropathy. In: StatPearls [Internet]. StatPearls Publishing; 2021. https://www.ncbi.nlm.nih.gov/books/NBK559020/
Gemignani F. Epidemiology and features of non-length-dependent small fiber neuropathy. Muscle Nerve. 2022;65(1):E1.
Gemignani F, Bellanova MF, Saccani E, Pavesi G. Non-length-dependent small fiber neuropathy: not a matter of stockings and gloves. Muscle Nerve. 2022;65:10-28. doi:10.1002/mus.27379
Joseph P, Arevalo C, Oliveira RKF, et al. Insights from invasive cardiopulmonary exercise testing of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Chest. 2021;160(2):642-651. doi:10.1016/j.chest.2021.01.082
Viceconti A, Geri T, De Luca S, et al. Neuropathic pain and symptoms of potential small-fiber neuropathy in fibromyalgic patients: a national on-line survey. Joint Bone Spine. 2021;88(4):105153.
Lair L, Gibbons C, Freeman R. Phantom sweating: a novel autonomic paresthesia. Clin Auton Res. 2008;18(6):352-354. doi:10.1007/s10286-008-0501-0
Calzetti S, Bellanova MF, Negrotti A, Saccani E, Capozzi A, Pietrini V. Non-length-dependent somatosensory small fiber pathology presenting with restless legs syndrome in pre-motor Parkinson's disease. Evidence from skin biopsy in four patients. J Clin Neurosci. 2019;69:139-142.
Egenolf N, Zu Altenschildesche CM, Kreß L, et al. Diagnosing small fiber neuropathy in clinical practice: a deep phenotyping study. Ther Adv Neurol Disord. 2021;14:17562864211004318.
Blitshteyn S. When POTS is the tip of the iceberg: rare cases of dysautonomia as a possible manifestation of another disorder. Lupus. 2021;30(5):697-701. doi:10.1177/0961203320988585
Novak P, Giannetti M, Weller E, Hamilton M, Castells M. Mast cell disorders are associated with decreased cerebral blood flow and small fiber neuropathy. Ann Allergy Asthma Immunol. 2021;S1081-1206(21):01155-1158.
Oaklander AL, Nolano M. Scientific advances in and clinical approaches to small-fiber polyneuropathy: a review. JAMA Neurol. 2019;76(10):1240-1251. doi:10.1001/jamaneurol.2019.2917
Raasing LRM, Vogels OJM, Veltkamp M, van Swol CFP, Grutters JC. Current view of diagnosing small fiber neuropathy. J Neuromuscul Dis. 2021;8(2):185-207. doi:10.3233/JND-200490
Vecchio M, Chiaramonte R, Romano M, Pavone P, Musumeci G, Mauro GL. A systematic review of pharmacologic and rehabilitative treatment of small fiber neuropathies. Diagnostics (Basel). 2020;10(12):1022. doi:10.3390/diagnostics10121022
Waheed W, Carey ME, Tandan SR, Tandan R. Post COVID-19 vaccine small fiber neuropathy. Muscle Nerve. 2021;64(1):E1-E2. doi:10.1002/mus.27251
Watad A, De Marco G, Mahajna H, et al. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines (Basel). 2021;9(5):435. doi:10.3390/vaccines9050435
Shouman K, Vanichkachorn G, Cheshire WP, et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res. 2021;31(3):385-394. doi:10.1007/s10286-021-00803-8
Souayah N, Ajroud-Driss S, Sander HW, Brannagan TH, Hays AP, Chin RL. Small fiber neuropathy following vaccination for rabies, varicella or Lyme disease. Vaccine. 2009;27(52):7322-7325. doi:10.1016/j.vaccine.2009.09.077
Koszewicz M, Markowska K, Waliszewska-Prosol M, et al. The impact of chronic co-exposure to different heavy metals on small fibers of peripheral nerves. A study of metal industry workers. J Occup Med Toxicol. 2021;16(1):12.
Dubey D, David WS, Amato AA, et al. Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies. Neurology. 2019;93(11):e1093-e1103. doi:10.1212/WNL.0000000000008091
Napolitano M, Patruno C, D'Andrea M, et al. Cutaneous sarcoidosis small-fiber neuropathy resembling leprosy. Ital J Dermatol Venerol. 2021;156(2):261-263. doi:10.23736/S0392-0488.20.06620-1
Oishi M, Mukaino A, Kunii M, et al. Association between neurosarcoidosis with autonomic dysfunction and anti-ganglionic acetylcholine receptor antibodies. J Neurol. 2021;268(11):4265-4279. doi:10.1007/s00415-021-10551-4
Schofield JR, Chemali KR. How we treat autoimmune small fiber polyneuropathy with immunoglobulin therapy. Eur Neurol. 2018;80(5-6):304-310. doi:10.1159/000498858
Tulbă D, Popescu BO, Manole E, Băicuș C. Immune axonal neuropathies associated with systemic autoimmune rheumatic diseases. Front Pharmacol. 2021;12:610585.
Pindi Sala T, Villedieu M, Damian L, et al. Long-term efficacy of immunoglobulins in small fiber neuropathy related to Sjögren's syndrome. J Neurol. 2020;267(12):3499-3507. doi:10.1007/s00415-020-10033-z
Fujii T, Lee EJ, Miyachi Y, et al. Antiplexin D1 antibodies relate to small fiber neuropathy and induce neuropathic pain in animals. Neurol Neuroimmunol Neuroinflamm. 2021;8(5):e1028. doi:10.1212/NXI.0000000000001028
Shinkarevsky Fleitman I, Nevo Y, Harel L, et al. Small-fiber neuropathy associated with autoinflammatory syndromes in children and adolescents. Muscle Nerve. 2020;61(6):791-796. doi:10.1002/mus.26857
Zis P, Sarrigiannis PG, Rao DG, Sanders DS, Hadjivassiliou M. Small fiber neuropathy in coeliac disease and gluten sensitivity. Postgrad Med. 2019;131(7):496-500. doi:10.1080/00325481.2019.1650609
Uyesugi B, Lippincott B, Dave S. Treatment of a painful keloid with botulinum toxin type A. Am J Phys Med Rehabil. 2010;89(2):153-155. doi:10.1097/PHM.0b013e3181c1ec11
González-Duarte A, Varma-Doyle A, Freeman R. Pure autonomic failure and the differential diagnosis of autonomic peripheral neuropathies. Curr Opin Neurol. 2021;34:675-682. doi:10.1097/WCO.0000000000000985
Jeziorska M, Atkinson A, Kass-Iliyya L, et al. Small fibre neuropathy in Parkinson's disease: comparison of skin biopsies from the more affected and less affected sides. J Parkinsons Dis. 2019;9(4):761-765. doi:10.3233/JPD-191697
Krämer HH, Rebhorn C, Geber C, Birklein F. Sympathetic and sensory nerve fiber function in multiple system atrophy and idiopathic Parkinson's disease. J Neurol. 2021;268(9):3435-3443. doi:10.1007/s00415-021-10514-9
Reach P, Lazareth I, Coudore F, et al. A reappraisal of the presence of small or large fiber neuropathy in patients with erythromelalgia. Neurophysiol Clin. 2021;51(4):349-355. doi:10.1016/j.neucli.2021.03.008
Devigili G, Tugnoli V, Penza P, et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain. 2008;131(Pt 7):1912-1925. doi:10.1093/brain/awn093
Jin Y, Wang W, Chen W, et al. Corneal confocal microscopy: A useful tool for diagnosis of small fiber neuropathy in type 2 diabetes. J Diabetes Investig. 2021;12:2183-2189. doi:10.1111/jdi.13616
Bitzi LM, Lehnick D, Wilder-Smith EP. Small fiber neuropathy: Swiss cohort characterization. Muscle Nerve. 2021;64(3):293-300. doi:10.1002/mus.27340
Unal-Cevik I, Orhan D, Acar-Ozen NP, Mamak-Ekinci EB. Small fiber functionality in patients with diabetic neuropathic pain. Pain Med. 2021;22(9):2068-2078. doi:10.1093/pm/pnab150
Farhad K. Current diagnosis and treatment of painful small fiber neuropathy. Curr Neurol Neurosci Rep. 2019;19(12):103. doi:10.1007/s11910-019-1020-1
Trevino JA, Novak P. TS-HDS and FGFR3 antibodies in small fiber neuropathy and dysautonomia. Muscle Nerve. 2021;64(1):70-76. doi:10.1002/mus.27245
Zeidman LA, Kubicki K. Clinical features and treatment response in immune-mediated small fiber neuropathy with trisulfated heparin disaccharide or fibroblast growth factor receptor 3 antibodies. J Clin Neuromuscul Dis. 2021;22(4):192-199. doi:10.1097/CND.0000000000000355
D'Onofrio L, Kalteniece A, Ferdousi M, et al. Small nerve fiber damage and langerhans cells in type 1 and type 2 diabetes and LADA measured by corneal confocal microscopy. Invest Ophthalmol vis Sci. 2021;62(6):5. doi:10.1167/iovs.62.6.5
Haroutounian S, Todorovic MS, Leinders M, et al. Diagnostic criteria for idiopathic small fiber neuropathy: a systematic review. Muscle Nerve. 2021;63(2):170-177. doi:10.1002/mus.27070
Peters MJH, Bakkers M, Merkies ISJ, Hoeijmakers JGJ, van Raak EPM, Faber CG. Incidence and prevalence of small-fiber neuropathy: a survey in the Netherlands. Neurology. 2013;81(15):1356-1360.
Bousbaïne van de Kerckhove L, Lefaucheur JP, Sorel M. Differences in stabilometric correlates of pain relief after wearing postural insoles for six weeks between chronic nociceptive and neuropathic foot pain. An open-label pilot study. Neurophysiol Clin. 2021;51(3):267-278. doi:10.1016/j.neucli.2021.04.002
Gordon Smith A, Robinson SJ. Idiopathic neuropathy, prediabetes and the metabolic syndrome. J Neurol Sci. 2006;242(1-2):9-14. doi:10.1016/j.jns.2005.11.020
Otis JD, Sanderson K, Hardway C, Pincus M, Tun C, Soumekh S. A randomized controlled pilot study of a cognitive-behavioral therapy approach for painful diabetic peripheral neuropathy. J Pain. 2013;14(5):475-482. doi:10.1016/j.jpain.2012.12.013
Weintraub MI, Herrmann DN, Smith AG, Backonja MM, Cole SP. Pulsed electromagnetic fields to reduce diabetic neuropathic pain and stimulate neuronal repair: a randomized controlled trial. Arch Phys Med Rehabil. 2009;90(7):1102-1109. doi:10.1016/j.apmr.2009.01.019
Rastogi A, Uppula P, Saikia U, Bhansali A. Effect of monochromatic infrared energy on quality of life and intraepidermal nerve fiber density in painful diabetic neuropathy: a randomized, sham control study. Neurol India. 2021;69(5):1331-1337. doi:10.4103/0028-3886.329614
Patel P, Zhang Y, Unikel LH, Edwards C. A case of sporadic erythromelalgia presenting with small fibre neuropathy. BMJ Case Rep. 2019;12(10):e230549. doi:10.1136/bcr-2019-230549
Namer B, Schmidt D, Eberhardt E, et al. Pain relief in a neuropathy patient by lacosamide: proof of principle of clinical translation from patient-specific iPS cell-derived nociceptors. EBioMedicine. 2019;39:401-408. doi:10.1016/j.ebiom.2018.11.042
Birnbaum J, Lalji A, Saed A, Baer AN. Biopsy-proven small-fiber neuropathy in primary Sjögren’s syndrome: neuropathic pain characteristics, autoantibody findings, and histopathologic features. Arthritis Care Res. 2019;71:936-948.
de Greef BTA, Hoeijmakers JGJ, Geerts M, et al. Lacosamide in patients with Nav1.7 mutations-related small fibre neuropathy: a randomized controlled trial. Brain. 2019;142(2):263-275. doi:10.1093/brain/awy329
Azmi S, Ferdousi M, Petropoulos IN, et al. Corneal confocal microscopy shows an improvement in small-fiber neuropathy in subjects with type 1 diabetes on continuous subcutaneous insulin infusion compared with multiple daily injection. Diabetes Care. 2015;38(1):e3-4. doi:10.2337/dc14-1698
Apfel SC, Schwartz S, Adornato BT, et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial. rhNGF Clinical Investigator Group. JAMA. 2000;284(17):2215-2221. doi:10.1001/jama.284.17.2215
McArthur JC, Yiannoutsos C, Simpson DM, et al. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291. Neurology. 2000;54(5):1080-1088. doi:10.1212/wnl.54.5.1080
Aradillas E, Schwartzman RJ, Grothusen JR, Goebel A, Alexander GM. Plasma exchange therapy in patients with complex regional pain syndrome. Pain Physician. 2015;18(4):383-394.
Zhou L. Small fiber neuropathy. Semin Neurol. 2019;39(05):570-577.
Maino P, Koetsier E, Kaelin-Lang A, Gobbi C, Perez R. Efficacious dorsal root ganglion stimulation for painful small fiber neuropathy: a case report. Pain Physician. 2017;20(3):E459-E463.
Hong J, Barnes M, Kessler N. Case study: use of vibration therapy in the treatment of diabetic peripheral small fiber neuropathy. J Bodyw Mov Ther. 2013;17(2):235-238. doi:10.1016/j.jbmt.2012.08.007
Menon D, Lewis EJH, Perkins BA, Bril V. Omega-3 nutrition therapy for the treatment of diabetic sensorimotor polyneuropathy. Curr Diabetes Rev. 2021;17.
Dabby R, Gilad R, Sadeh M, Lampl Y, Waterìmberg N. Acute steroid responsive small-fiber sensory neuropathy: a new entity. J Peripher Nerv Syst. 2006;11:47-52.
Pereira PR, Viala K, Maisonobe T, et al. Sjögren sensory neuronopathy (Sjögren Ganglionopathy): long-term outcome and treatment response in a series of 13 cases. Medicine (Baltimore). 2016;95(19):e3632. doi:10.1097/MD.0000000000003632
Saito H, Yamaguchi T, Adachi Y, et al. Neurological symptoms of sarcoidosis-induced small fiber neuropathy effectively relieved with high-dose steroid pulse therapy. Intern Med. 2015;54(10):1281-1286. doi:10.2169/internalmedicine.54.3702
Yuki N, Chan AC, Wong AHY, et al. Acute painful autoimmune neuropathy: a variant of Guillain-Barré syndrome. Muscle Nerve. 2018;57:320-324.
Favoni V, Liguori R, Incensi A, Fileccia E, Donadio V. The incidental finding of elevated anti GQ1B antibodies in a patient with selective small fiber neuropathy. J Neurol Sci. 2018;388:192-194. doi:10.1016/j.jns.2018.03.030
Tavee JO, Karwa K, Ahmed Z, Thompson N, Parambil J, Culver DA. Sarcoidosis-associated small fiber neuropathy in a large cohort: Clinical aspects and response to IVIG and anti-TNF alpha treatment. Respir Med. 2017;126:135-138. doi:10.1016/j.rmed.2017.03.011
Culver DA, Dahan A, Bajorunas D, et al. Cibinetide improves corneal nerve fiber abundance in patients with sarcoidosis-associated small nerve fiber loss and neuropathic pain. Invest Ophthalmol vis Sci. 2017;58(6):BIO52-BIO60.
Pitarokoili K, Maier A, de Moya Rubio EC, et al. Maintenance therapy with subcutaneous immunoglobulin in a patient with immune-mediated neuropathic postural tachycardia syndrome. J Transl Autoimmun. 2021;4:100112.
Cook MK, Jordan M. Autoimmune small fiber neuropathy associated with Ehlers-Danlos syndrome treated with intravenous immunoglobulins. J Clin Neuromuscul Dis. 2021;22(3):160-163. doi:10.1097/CND.0000000000000341
Kelley MA, Oaklander AL. Association of small-fiber polyneuropathy with three previously unassociated rare missense SCN9A variants. Can J Pain. 2020;4(1):19-29. doi:10.1080/24740527.2020.1712652
Wakasugi D, Kato T, Gono T, et al. Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjögren's syndrome. Mod Rheumatol. 2009;19(4):437-440. doi:10.1007/s10165-009-0180-2
Parambil JG, Tavee JO, Zhou L, Pearson KS, Culver DA. Efficacy of intravenous immunoglobulin for small fiber neuropathy associated with sarcoidosis. Respir Med. 2011;105(1):101-105. doi:10.1016/j.rmed.2010.09.015